Syneos Health

At this year’s CNS Summit, we’re taking thought leadership beyond the main stage. The Syneos Health Podcast Booth will be live onsite, featuring in-depth discussions with experts across neuroscience, data science and patient experience. These conversations will spotlight the trends redefining how treatments are developed, delivered and experienced. Follow along on our LinkedIn for future episode releases and if you’re attending CNS Summit, stop by the booth and say hi to the team. #CNSSummit2025 #ClinicalDevelopment #Neuroscience #ClinicalResearch #Innovation #Leadership #SyneosHealth

Coming off the heels of ESMO 2025, the conversation around antibody-drug conjugates (ADCs) has never been more timely. ADCs are reshaping oncology by pairing targeted therapies with potent payloads — but challenges in biology, chemistry and trial design mean we’re still far from the peak. Our latest whitepaper explores what it will take to unlock next-generation ADC success, from novel payloads and smarter linker chemistry to biomarker-driven trials and combination approaches. Read more: https://lnkd.in/eqEY9DyX #SyneosHealth #Oncology #ESMO25 #ADCs #CancerResearch

Did you know that Atopic dermatitis, a form of Eczema, affects millions worldwide, and developing effective therapies requires careful planning and expertise? At Syneos Health, we partner with sponsors globally to design tailored study protocols, ensure precise patient recruitment and implement rigorous data collection methodologies — helping bring new treatments to those who need them most. Learn more about our dermatology research and how we are building on the promise of innovation: https://lnkd.in/ed3kfGcj #EczemaAwarenessMonth #AtopicDermatitis #ClinicalResearch #PatientCare #SyneosHealth

As biopharma companies scale healthcare delivery, we are excited to announce a new partnership that tackles current access challenges while adapting to evolving therapies, payer demands and the need for measurable impact. Access the breaking news edition of the Syneos Health Weekly Sync to read the press release. #SyneosHealth #PatientAccess #CareMetx #HealthcareInnovation #Partnership

Our clinical, consulting and communications teams have joined forces to help shape a new white paper on tumour- agnostic innovation – funded by AstraZeneca, Bayer, Daiichi Sankyo and MSD. Informed by insights from a multidisciplinary expert working group, the paper explores how Europe can accelerate the adoption of tumour-agnostic therapies: the next step in precision oncology that targets molecular alterations across cancer types, regardless of origin or location. We are at the crossroads of tumour-agnostic innovation. These therapies have the potential to expand treatment options and improve outcomes for patients. However, health systems in Europe must evolve to keep up with the pace of scientific progress and ensure patients can fully benefit. At Syneos Health, we are grateful to have been a part of this initiative and thank the working group members for sharing their time and views. Read the paper here: https://lnkd.in/e7K7j6KB #Oncology #PrecisionMedicine #TumourAgnostic

Commercial strategies must evolve with specialty medicine. With 80% of FDA approvals now classified as specialty products, commercialization models can’t stay the same. In a conversation with Fierce Pharma, Matt Lehmann, EVP of Global Commercial Solutions at Syneos Health, shares how removing obstacles along the patient journey, advancing patient support services and leveraging AI-powered insights through Kinetic, Predictive Storytelling and the Mindset Engine, is transforming engagement and access. Watch the full interview to learn how Syneos Health is helping biopharma brands connect innovation to impact — and get medicines into the hands of patients. Watch now: https://lnkd.in/eCvEVXXr #SyneosHealth #Commercialization #Pharma #SpecialtyMedicine #PatientAccess #AIinPharma #Kinetic #PredictiveStorytelling

Join the Financial Times in Palo Alto or online this November for Financing Biotech Innovation, in partnership with Syneos Health. How can clinical-stage biotechs stand out in a highly competitive environment where access to investment remains limited? Influential voices from pharma, biotech and investment will come together to explore how the industry can unlock new strategies for securing drug development funding. Be part of the discussion with leading experts shaping the future of biotech innovation and investment. Srini Akkaraju, Samsara BioCapital Steven Basta, Phathom Pharmaceuticals Christiana Bardon M.D., MPM BioImpact Thomas W. Chalberg, PhD, Genascence Corporation Aileen Fernandes, Arcellx Harish Shantharam, CFA, ALX Oncology Amit Etkin, Alto Neuroscience Michael Sarshad, Syneos Health  Andy Tincu PhD MBA, Syneos Health Patrick Temple-West, Financial Times Register for free now: https://lnkd.in/exYrNBDx

We’re thrilled to be hosting the inaugural SyncUp Summit this October, a three-day event designed to accelerate the delivery of transformative therapies to patients. This invitation-only gathering will spotlight the voices shaping the future of drug development — from patients and caregivers to experts in policy, AI and clinical innovation. Together, we’ll move beyond conversation — turning insight into action. Stay tuned for exclusive post-Summit insights. #SyneosHealth #SyncUpSummit #ClinicalTrials #DrugDevelopment #LifeSciencesLeadership

AAO 2025 is this weekend! As the ophthalmology community gathers to share breakthroughs in vision science, we’re spotlighting how Syneos Health partners with innovators to restore vision and improve lives. With 400+ ophthalmology projects executed since 2019 and 50+ approved eye care products developed and commercialized since 2010, our experts bring deep experience across drugs, devices and diagnostics in vision care. Watch the video below to see how we’re advancing ophthalmology innovation and explore more at: https://lnkd.in/eCXyMNKH Reach out to our ophthalmology leaders to connect on the ground at AAO: Jonathan Angelastro, Laszlo B., Jason Tibbs, Tracey Roberts (Dearing) #AAO2025 #Ophthalmology #SyneosHealth